Short-Term Blood Pressure, Noradrenergic, and Vascular Effects of Nocturnal Home Hemodialysis

Hypertension

Volumn 42, Issue 5, 2003, Pages 925-931

  Chan, Christopher T ^a   Harvey, Paula J ^a   Picton, Peter ^a   Pierratos, Andreas ^b   Miller, Judith A ^a   Floras, John S ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE   (Canada)

Author keywords

Blood pressure; Catecholamines; Endothelium; Hemodialysis; Hemodynamics; Muscle, smooth, vascular

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; ENDOTHELIUM CELL; EXTRACELLULAR FLUID; FEMALE; HEART STROKE VOLUME; HEMODIALYSIS; HIGH RISK PATIENT; HOME CARE; HUMAN; HYPEREMIA; KIDNEY FAILURE; MALE; NORADRENALIN RELEASE; PRESSOR RESPONSE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUBSTITUTION THERAPY; VASCULAR SMOOTH MUSCLE;

ADULT; ANGIOTENSIN II; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HEMODIALYSIS, HOME; HEMODYNAMIC PROCESSES; HUMANS; MALE; NOREPINEPHRINE; VASCULAR RESISTANCE; VASODILATION;

EID: 0242609869     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000097605.35343.64     Document Type: Article

References (41)

1. Ifudu O. Care of patients undergoing hemodialysis. N Engl J Med. 1998;339:1054-1062.
2. Wolfe RA, Ashby VB, Daugirdas JT Agodoa, LY Jones CA, Port FK. Body size, dose of hemodialysis, and mortality. Am J Kidney Dis. 2000; 35:80-88.
3. Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, Salvador M, Chamontin B. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57:2485-2491.
4. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cateliotti A, Stancanelli B, Malatino LS. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation. 2002;105:1354-1359.
5. Tycho Vuurmans JL, Boer WH, Blankestijn PJ, Koomans HA. Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol. 2002;13:177-183.
6. Pannier B, Guerin AP, Marchais SJ, Metivier F, Safar, ME, London G. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int. 2000;57:1091-1099.
7. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol. 1995;5:2024-2031.
8. Harnett JD, Foley RN, Kent GM, Barre P, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995;47:884-890.
9. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, Langos V, Uldall R. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol. 1998;9:859-868.
10. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002;61:2235-2239.
11. Chan CT, Floras JS, Miller JA, Pierratos A. Improvement in ejection fraction by nocturnal hemodialysis in end-stage renal disease patients with co-existing heart failure. Nephrol Dial Transplant. 2002;17: 1518-1521.
12. Chen NX, O'Neill KD, Duan D, Moe SM. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int. 2002;62:1724-1731.
13. Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG. Abnormalities in the renal and vascular responses to LBNP in humans with early diabetes. Am J Physiol. 1994;266:R442-R450.
14. Naughton MT, Rahman MA, Hara K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation. 1995;91:1725-1731.
15. Daugirdas JT, Greene T, Depner TA, Gotch FA, Star RA. Relationship between apparent (single-pool) and true (double-pool) urea distribution volume. Kidney Int. 1999;56:1928-1933.
16. Jindal KK, Manuel A, Goldstein MB. Percent reduction in blood urea concentration during hemodialysis (PRU): a simple and accurate method to estimate Kt/V urea. ASAIO Trans. 1987;33:286-288.
17. Kopple JD. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2001:37:S66-S70.
18. Miller JA, Floras JS, Skorecki KL, Blendis LM, Logan AG. Renal and humoral responses to sustained cardiopulmonary baroreceptor deactivation in humans. Am J Physiol. 1991;260:R642-R648.
19. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673-2678.
20. Kendix M. Dialysis modality selection among patients attending free-standing dialysis facilities. Health Care Financ Rev. 1997;18:3-21.
21. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912-1918.
22. Onesti G, Kim K, Greco J, del Guercio ET, Fernandes M, Swartz C. Blood pressure regulation in end-stage renal disease and anephric man. Circ Res. 1975;36:145-152.
23. McGregor DO, Buttimore AL, Lynn KL, Nicholls MG, Jardine DL. A comparative study of blood pressure control with short in-center versus long home hemodialysis. Blood Purif. 2001;19:293-300.
24. Luik AJ, v d Sande FM, Weideman P, Cheriex E, Kooman JP, Leunissen KM. The influence of increasing dialysis treatment time and reducing dry weight on blood pressure control in hemodialysis patients: a prospective study. Am J Nephrol. 2001;21:471-478.
25. Katzarski KS, Charra B, Luik AJ, Nisell J, Divino Filho JC, Leypoldt JK, Leunissen KM, Laurent G, Bergstrom J. Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant. 1999;14:369-375.
26. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995;25: 878-882.
27. Recordafi GM, Moss NG, Genovesi S, Rogenes PR. Renal receptors in the rat sensitive to chemical alterations of their environment. Circ Res. 1980;46:395-405.
28. Katholi RE, McCann WP, Woods WT. Intrarenal adenosine produces hypertension via renal nerves in the one-kidney, one clip rat. Hypertension. 1985;7(suppl I):I-88-I-93.
29. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002;106:1974-1979.
30. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med. 1999;340:1321-1328.
31. Chan C, Hanly P, Gabor J, Picton P, Pierratos A, Floras JS. Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int. In press.
32. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191-196.
33. Hijmering ML, Stroes ES, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol. 2002;39: 683-688.
34. Cross JM, Donald A, Vallance PJ, Deanfield JE, Woolfson RG, MacAllister RJ. Dialysis improves endothelial function in humans. Nephrol Dial Transplant. 2001;16:1823-1829.
35. Hand MF, Haynes WG, Webb DJ. Hemodialysis and L-arginine, but not D-arginine. correct renal failure-associated endothelial dysfunction. Kidney Int. 1998;53:1068-1077.
36. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-265.
37. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM. Phosphate regulation of vascular smooth muscle cell calcificationn. Circ Res. 2000;87:E10-E17.
38. Friedman AN, Bostom AG, Levey AS, Rosenberg IH, Selhub J, Pierratos A. Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis. J Am Soc Nephrol. 2002;13:265-268.
39. Schwarz M, Katz SD, Demopoulos L, Hirsch H, Yuen JL, Jondeau G, LeJemtel TH. Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure. Circulation. 1994;89:1609-1614.
40. Hara K, Floras JS. After-effects of exercise on haemodynamics and muscle sympathetic nerve activity in young patients with dilated cardiomyopathy. Heart. 1996;75:602-608.
41. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010-2019.